China post-approval commitment (PAC) study of avalglucosidase alfa in participants with IOPD

Trial Identifier:	LPS18086
Sponsor:	Genzyme, a Sanofi Company
Start Date:	May 2025
Primary Completion Date:	May 2028
Study Completion Date:	May 2028
Condition:	Pompe Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Shanghai, China, 200127

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.